American Society of Hematology, Blood, 4(129), p. 473-483, 2017
DOI: 10.1182/blood-2016-07-729954
Full text: Download
Key Points FLs harbor more recurrent mutations in the BCR signaling pathway, SWI/SNF complex, and histone genes than previously known. Novel recurrent mutations affecting BTK, SYK, and HVCN1 may have therapeutic and prognostic implications for FL.